Prognosis in Acute Lymphoblastic Leukemia of Childhood as Determined by Cytogenetic Studies at Diagnosis

Authors:
  • MBMarilyn Blake
    Marilyn Blake

Abstract
Fifty‐one children with acute lymphoblastic leukemia on a common protocol of treatment were classified according to presence or absence of chromosomal abnormalities found at the time of diagnosis in bone marrow and/ or blood. Twenty‐two or 43% had normal karyotypes while 29 (57%) had clonal abnormalities using the Giemsa‐trypsin banding technique. Thirteen of the 29 (45%) chromo‐somally abnormal patients relapsed while only three of 21 (14%) with normal karyotypes have relapsed with a median follow‐up of 49.5 months (42‐76 months). (One child with a normal karyotype did not respond to therapy.) Several hypotheses have been offered to attempt to explain the significantly better prognosis of patients with no observable initial chromosomal aberrations.

This publication has 12 references indexed in Scilit: